IMW 2019 | IMW 2019: the promising introduction of new treatment strategies

Paul Richardson

Dr Paul Richardson, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses the recent presentation of novel therapies at the International Myeloma Workshop (IMW) 2019, in Boston, MA. Particularly, he highlights the use of antibody-drug conjugates and targeted therapeutics.

Share this video  
Similar topics